Cell-specific drug targeting in the lung

Area of Science:

• Pharmacology
• Biochemistry
• Drug Delivery Systems

Background:

• Non-targeted drug delivery faces limitations like poor bioavailability, stability, and off-target effects.
• Cell-specific targeting offers a promising strategy to overcome these challenges in lung therapeutics.
• Understanding biochemical and molecular mechanisms is crucial for effective lung drug delivery.

Purpose of the Study:

• To review cell-specific targeted drug delivery approaches in the lung.
• To discuss strategies at the biochemical and molecular levels.
• To provide an overview of current advancements and pharmaceutical parameters.

Main Methods:

• Literature review of cell-specific targeted lung delivery.
• Analysis of small molecule drugs, biologics, and synthetic hybrids.
• Examination of site-activated drugs and novel delivery systems.

Main Results:

• Identified four main categories of cell-specific lung targeting: intracellular small molecules, extracellular biologics/hybrids, site-activated drugs, and delivery systems.
• Discussed pharmaceutical and biochemical factors influencing drug fate at delivery sites.
• Highlighted current research and advancements in the field.

Conclusions:

• Cell-specific targeting significantly improves therapeutic selectivity and drug efficacy in the lungs.
• Further research into biochemical and molecular targeting mechanisms is essential.
• Advanced delivery systems hold great potential for future lung disease treatments.